fbpx
Medical Innovation Exchange

Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets in light of data and competition

https://www.fiercebiotech.com/biotech/amgen-takes-bites-out-pipeline-dropping-bcma-and-psma-assets-light-data-and-competition

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.